Sign in

CIK 0001628171 · Large accelerated filer

Revolution Medicines, Inc.

Sign in to watch
Ticker
RVMD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
472029180
Phone
650-481-6801
Business address
700 SAGINAW DR, REDWOOD CITY, CA, 94063

Securities

  • RVMD Common Stock Nasdaq
  • RVMDW Warrant Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$85,328,124
in 21 filings, $85.3M under 10b5-1 plans

Net −$85,328,124. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. GOLDSMITH MARK A −$20.8M See Remarks sold 28% of stake
  2. Kelsey Stephen Michael −$19.8M See Remarks sold 26% of stake
  3. Kim Lorence H. −$15.0M Director sold 100% of stake
  4. Cislini Jeff −$12.7M SVP & General Counsel sold 54% of stake
  5. Anders Jack −$7.5M Chief Financial Officer sold 25% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-09-22 ANDERSON ELIZABETH M Director Sale 10b5-1 −1,500 $194.59 $292K 4,433
2026-09-22 ANDERSON ELIZABETH M Director Sale 10b5-1 −100 $195.15 $20K 4,333
2026-09-22 ANDERSON ELIZABETH M Director Option exercise · Stock Option (Right to Buy) 10b5-1 −5,070 1,095
2026-09-18 Mancini Anthony See Remarks Sale 10b5-1 −1,764 $196.94 $347K 40,352
2026-09-16 Mancini Anthony See Remarks Sale 10b5-1 −27 $195.05 $5K 43,863
2026-09-16 Mancini Anthony See Remarks Sale 10b5-1 −1,747 $199.30 $348K 42,116
2026-09-16 Cislini Jeff SVP & General Counsel Sale 10b5-1 −52 $195.01 $10K 55,855
2026-09-16 Cislini Jeff SVP & General Counsel Sale 10b5-1 −3,314 $199.30 $660K 52,541
2026-09-16 Sandler Alan B. Chief Development Officer Sale 10b5-1 −5 $194.96 $975 53,204
2026-09-16 Sandler Alan B. Chief Development Officer Sale 10b5-1 −336 $199.30 $67K 52,868
2026-09-16 Anders Jack Chief Financial Officer Sale 10b5-1 −61 $195.00 $12K 123,208
2026-09-16 Anders Jack Chief Financial Officer Sale 10b5-1 −3,992 $199.30 $796K 119,216
2026-09-16 Kelsey Stephen Michael See Remarks Sale 10b5-1 −85 $195.01 $17K 291,791
2026-09-16 Kelsey Stephen Michael See Remarks Sale 10b5-1 −5,484 $199.30 $1.1M 286,307
2026-09-16 Horn Margaret A Chief Operating Officer Sale 10b5-1 −76 $195.01 $15K 154,571
2026-09-16 Horn Margaret A Chief Operating Officer Sale 10b5-1 −4,891 $199.30 $975K 149,680
2026-09-16 GOLDSMITH MARK A See Remarks Sale 10b5-1 −213 $195.01 $42K 267,117
2026-09-16 GOLDSMITH MARK A See Remarks Sale 10b5-1 −13,775 $199.30 $2.7M 253,342
2026-09-11 Kelsey Stephen Michael See Remarks Option exercise 10b5-1 +52,500 $42.45 $2.2M 344,376
2026-09-11 Kelsey Stephen Michael See Remarks Option exercise 10b5-1 +40,031 $40.74 $1.6M 384,407

Page 3 of 18 · 352 trades